We are live on ! Find out more
EPZM

Epizyme, Inc
EPZM

Delisted

EPZM was delisted on the 11th of August, 2022.

Back to rankings

0 hedge funds and large institutions have $4K invested in Epizyme, Inc in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 93 → 0 (-93)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $187M → $4K (-$187M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 93

Holders
–
Holders Change
-93
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
93
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RM
RP Management
New York
-$46.8M
2
Primecap Management
Primecap Management
California
-$24.5M
3
NM
Newtyn Management
New York
-$11.1M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$11.1M
5
RSCM
Rock Springs Capital Management
Maryland
-$11M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
– -$1.02M -691,458 Closed
Charles Schwab
27
Charles Schwab
California
– -$1.01M -686,966 Closed
E
28
Ergoteles
New York
– -$954K -649,100 Closed
GCIA
29
Gabelli & Co Investment Advisers
New York
– -$709K -482,200 Closed
Citigroup
30
Citigroup
New York
– -$678K -461,240 Closed
Renaissance Technologies
31
Renaissance Technologies
New York
– -$578K -393,000 Closed
HWAM
32
Hennion & Walsh Asset Management
New Jersey
– -$488K -332,004 Closed
Northern Trust
33
Northern Trust
Illinois
– -$398K -270,917 Closed
BCM
34
Bridgeway Capital Management
Texas
– -$396K -269,200 Closed
JC
35
JBF Capital
Colorado
– -$382K -260,000 Closed
Macquarie Group
36
Macquarie Group
Australia
– -$299K -203,200 Closed
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
– -$272K -184,964 Closed
YCM
38
Yakira Capital Management
Connecticut
– -$257K -174,500 Closed
T. Rowe Price Associates
39
T. Rowe Price Associates
Maryland
– -$188K -128,228 Closed
FLC
40
Fifth Lane Capital
Texas
– -$147K -100,000 Closed
CL
41
CSS LLC
Illinois
– -$137K -93,999 Closed
AQR Capital Management
42
AQR Capital Management
Connecticut
– -$127K -86,478 Closed
Qube Research & Technologies (QRT)
43
Qube Research & Technologies (QRT)
United Kingdom
– -$110K -74,695 Closed
Group One Trading
44
Group One Trading
Illinois
– -$109K -74,339 Closed
Legal & General Group
45
Legal & General Group
United Kingdom
– -$102K -69,205 Closed
LP
46
LMR Partners
United Kingdom
– -$100K -68,156 Closed
UBS Group
47
UBS Group
Switzerland
– -$98K -66,512 Closed
BNP Paribas Financial Markets
48
BNP Paribas Financial Markets
France
– -$91.1K -61,993 Closed
FIA
49
FNY Investment Advisers
New York
– -$73K -50,000 Closed
Bank of New York Mellon
50
Bank of New York Mellon
New York
– -$68K -46,532 Closed
1
2
3 4

EPZM Hedge Fund Activity: Q3 2022 in Review

0 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q3 2022, worth a combined $4K — down 100% from $187M a quarter earlier.

Sellers outnumbered buyers: 93 funds closed out of EPZM and 0 opened new positions — a net loss of 93 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RP Management, exiting entirely with an estimated $46.8M sold.

  • 0 institutional investors held Epizyme, Inc (EPZM) as of Q3 2022, down from 93 in Q2 2022.
  • Funds reported $4K of Epizyme, Inc stock for Q3 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Epizyme, Inc positions in Q3 2022 and 93 closed out, a net change of -93 holders.
  • The largest Epizyme, Inc seller in Q3 2022 was RP Management, an estimated $46.8M sold.

Based on aggregated 13F filings for Q3 2022.